Protocols - Hemorio
Protocols - Hemorio
Protocols - Hemorio
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
ADVERSE EFFECTS RELATED TO THE TRANSFUSIONS IN FALCIFORM DISEASE:<br />
In addition to the inherent adverse effects to any and all blood transfusion, there is one, in particular, that it<br />
may attack the person who has Falciform Disease, which is:<br />
BYSTANDER HEMOLYSIS: that, by definition, is a complication of the late hemolytic reaction, in which the<br />
red blood cells of the receptor are destroyed during an immune hemolytic reaction.<br />
2 – TRANSFUSIONAL CONDUCT AT THE MAJOR THALASSEMIA AND INTERMEDIATE<br />
HYPERTRANSFUSION: the subjects will be transfused every 2 to 3 weeks, with the purpose to keep the<br />
Hb at least 10 g/dl and less than 15g/dL.<br />
INDICATIONS:<br />
- Major thalassemia – all cases<br />
- Intermediate thalassemia – with facial changes, retardation in the growth, pathologic fractures and/or<br />
extramedullary hematopoiesis.<br />
CHARACTERISTICS OF THE TRANSFUSIONAL COMPONENTS<br />
Transfuse de-leukocytated blood prophylactically.<br />
Transfuse phenotyped blood for the antigens Rh and Kell (Rh1, Rh2, Rh3, Rh4, K1).<br />
Whenever possible, also respect the antigens Fy a and Fy b , Jk a and Jk b , S and s.<br />
In allo-immunizing subjects, transfuse red blood cells destituted of the antigen(s) against which the subject<br />
has developed the antibody, in addition to mandatory respect the antigens Rh1, Rh2, Rh3, Rh4, K1, Fy a and<br />
Fy b , Jk a and Jk b , S and s.<br />
The interval between each transfusion will be determined case by case, due to the usage of transfusion<br />
and the levels of pre-transfusion hemoglobin. As a general rule, this interval must be of two to three<br />
weeks.<br />
The volume to be transfused must also be determined case by case, due to the weight of the subject and<br />
the response to the transfusions.<br />
The serum dosage of ferritin of the subject must be verified every three months. Levels of ferritin above<br />
1,000 µg% indicate that the case must be evaluated and discussed jointly by the Hemotherapy and<br />
Hematology Services.<br />
3 – TRANSFUSIONAL CONDUCT AT THE HERITABLE SPHEROCYTOSIS AND G6PD DEFICIENCY<br />
- Transfusions when symptomatic and hemoglobin